[Clinical problems of systematic prostate needle biopsy in the detection of prostate cancer]
- PMID: 12557699
[Clinical problems of systematic prostate needle biopsy in the detection of prostate cancer]
Abstract
Prostate needle biopsy is necessary for the pathological diagnosis of prostate cancer. Currently, sextant systemic random biopsy under transrectal ultrasound is widely used. However, several clinical problems with this biopsy have been discussed. This review focuses on these clinical points in prostate biopsy.
Similar articles
-
Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.J Urol. 2005 Jun;173(6):1926-9. doi: 10.1097/01.ju.0000158444.56199.03. J Urol. 2005. PMID: 15879783
-
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.J Urol. 2004 Sep;172(3):900-4. doi: 10.1097/01.ju.0000134619.72675.8d. J Urol. 2004. PMID: 15310993
-
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028. Urology. 2004. PMID: 14972481
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
-
Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.BJU Int. 2005 Jun;95(8):1146-52. doi: 10.1111/j.1464-410X.2005.05540.x. BJU Int. 2005. PMID: 15877724 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical